๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Sa1905 Predictors of Clinical Response, Re-Induction Dose, and Dose Increase With Cetolizumab Pegol in Crohn's Disease

โœ Scribed by Stein, Adam C.; Rubin, David T.; Hanauer, Stephen B.; Cohen, Russell D.

Book ID
122289483
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
113 KB
Volume
142
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Comparison of two dosing methods for ind
Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohn's disease: A randomized placebo-controlled trial
โœ Arie Levine; Michal Kori; Gabriel Dinari; Efrat Broide; Ron Shaoul; Baruch Yerus ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB ๐Ÿ‘ 4 views

## Background: Oral budesonide has been found to be comparable to systemic corticosteroids in mild to moderately active crohn's disease (cd). remission rates in pediatric studies to date have been suboptimal (47%-55%), even though patients with colonic involvement were excluded in some studies. in